Biological Science: Research Developments and Innovations Vol. 6

Hybrid breeding has shaped commercial production of mulberry silk, yet the connection between the phenotypic advantage of crosses, its underlying biology and its reliability under commercial rearing remains incompletely resolved. This critical narrative review evaluates heterosis in the domesticated mulberry silkworm, Bombyx mori, with attention to parental genetic resources, cross architecture, reciprocal and sex-specific effects, molecular mechanisms, stress adaptation, reeling quality and farm-level performance. Peer-reviewed genetic, genomic, transcriptomic, proteomic and breeding studies were appraised alongside evidence from controlled-rearing and farmer-field assessments published through 14 August 2026. Heterosis emerges as a trait-, cross- and environment-dependent outcome rather than an intrinsic property of any hybrid class. Evidence for favourable variation in cocoon and silk-related traits is substantial, but comparisons depend strongly on whether the reference is a parental mean, the superior parent or a commercially relevant check. Single, three-way and double crosses cannot be ranked universally, and general combining ability, genetic distance and marker associations are informative without being sufficient predictors of field performance. Molecular studies identify changes in metabolic regulation, protein synthesis and tissue-specific gene expression, with markedly different expression patterns among hybrid systems. These findings support biological plausibility but seldom identify causally necessary alleles or demonstrate independent field benefits. A smaller emerging evidence base links thermotolerant parentage and double-hybrid performance to cocoon and reeling outcomes under tropical conditions; replication, exposure measurement, seed quality and economic assessment are often inadequate for broad deployment claims. A proposed translation framework links verified parental identity, factorial testing, environmental robustness, independent reeling assessment and producer-level economics. Future progress requires multi-location randomised trials, validated genomic prediction and integrated assessments of resilience and raw-silk quality. Commercial usefulness should be judged by reproducible, risk-adjusted performance rather than heterosis percentages alone.